Occudo Quantitative Strategies’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Occudo Quantitative Strategies’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,381	Closed	-$1.37M	–	1409
2021 Q4	$1.37M	Buy	+119,381	New	+$1.35M	0.12%	255
2021 Q3	–	Sell	-15,698	Closed	-$175K	–	1213
2021 Q2	$175K	Buy	+15,698	New	+$176K	0.03%	736

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Occudo Quantitative Strategies's NFH Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 119,381 shares — an estimated $1.37M sold.

Occudo Quantitative Strategies first reported a position in NFH in Q2 2021 and held it in 2 quarters. The position peaked at $1.37M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Occudo Quantitative Strategies reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Occudo Quantitative Strategies sold 119,381 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $1.37M.
Occudo Quantitative Strategies first reported a position in New Frontier Health Corporation Ordinary Shares in Q2 2021 and held it in 2 quarters.
Occudo Quantitative Strategies's New Frontier Health Corporation Ordinary Shares position peaked at $1.37M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.